Merck to acquire respiratory drug maker, Verona Pharma for $10 billion
Merck, known as MSD outside of the United States and Canada, and Verona Pharma plc, a biopharmaceutical company focused on respiratory diseases, announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, …